Eagle Craig reports OS Therapies (OSTX) director role, no trades
Rhea-AI Filing Summary
OS Therapies Inc submitted a Form 3 initial insider report for director Eagle Craig. The Form 3 identifies Craig as a director and not an officer or ten percent owner. It does not report any buy or sell transactions or any derivative security transactions for this insider.
Positive
- None.
Negative
- None.
Key Figures
Reported buy transactions: 0
Reported sell transactions: 0
Derivative transactions: 0
3 metrics
Reported buy transactions
0
Buy transactions in the Form 3 transaction summary for Eagle Craig
Reported sell transactions
0
Sell transactions in the Form 3 transaction summary for Eagle Craig
Derivative transactions
0
Derivative transaction count in the Form 3 summary for Eagle Craig
Key Terms
Rule 10b5-1, derivative positions, beneficial ownership
3 terms
Rule 10b5-1 regulatory
"Footnotes may reference Rule 10b5-1 trading plans or arrangements"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
derivative positions financial
"derivativeSummary contains remaining derivative positions (unexercised options, warrants)"
Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.
beneficial ownership regulatory
"Any disclaimers of beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 3 for OS Therapies (OSTX) disclose about Eagle Craig?
The Form 3 shows that Eagle Craig is a director of OS Therapies Inc (OSTX). It classifies him as a director only, with no officer role and not a ten percent owner, and reports no insider transactions or derivative security transactions.
Is Eagle Craig considered a ten percent owner of OS Therapies (OSTX) in this Form 3?
No. The Form 3 classifies Eagle Craig as a director of OS Therapies Inc (OSTX) and indicates he is not a ten percent owner. The report therefore treats him as an insider based on directorship rather than large share ownership.
Does the OS Therapies (OSTX) Form 3 report any insider trades by Eagle Craig?
No insider trades are reported. The transaction summary shows 0 buy and 0 sell transactions and no derivative transactions for Eagle Craig, meaning this Form 3 serves solely as an initial status report without recording any trades.
Are any derivative security positions reported for Eagle Craig in OS Therapies (OSTX)?
No derivative security activity is reported. The derivative transaction count is 0 and the derivative summary is empty, so this Form 3 does not list any options, warrants, or other derivative transactions for Eagle Craig at this time.
What type of SEC filing is this for OS Therapies (OSTX)?
This is a Form 3, the SEC’s initial statement of insider status. It records that Eagle Craig is a director of OS Therapies Inc (OSTX) and provides a transaction summary, which in this case shows no reported trades or derivative transactions.